Stay updated on Pembrolizumab for Recurrent Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Publications section wording updated to replace 'the study results' with 'the results of the study' and to add a version tag (Revision: v3.3.2) while removing the older tag (v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:51:44.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The government funding and operating status notice has been removed from the page, while core study details, eligibility criteria, and contact information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:30:01.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    No significant changes detected in the page contents or structure between screenshots; the primary study details remain the same.
    Difference
    0.4%
    Check dated 2025-10-27T21:11:16.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Version bump to v3.2.0 accompanied by a government-operating-status notice; replaces the earlier v3.1.0 tag.
    Difference
    3%
    Check dated 2025-10-06T08:57:39.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Updated the site/page version from v3.0.2 to v3.1.0, indicating a new release without other substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-29T07:34:06.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Page updated to revision v3.0.2; v3.0.1 is removed, and the Back to Top link is deleted. No observable changes to core content, pricing, stock, or time slots.
    Difference
    0.2%
    Check dated 2025-09-14T23:23:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Recurrent Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page.